НЕЙРОМЕДИАТОРНЫЕ МЕХАНИЗМЫ ОПИАТНОЙ НАРКОМАНИИ (обзор литературы)
Аннотация
На основе обширного анализа литературы охарактеризованы основные нейромедиаторные нарушения при потреблении опиатов. Показана роль опиоидныхрецепторов в формировании патохимических изменений в ЦНС при опиатной наркомании. Представлены данные о влиянии однократного и хронического введения морфина на функционирование различных нейромедиаторных систем головного мозга.
Литература
Беляев, Ю.В. Фармакологические аспекты обезболивания/Ю.В. Беляев -Л.:Медицина.-1983. -С. 64.
Головко А.И., Коноплин Д.А., Некрасов Ю.А. и др. Нейрохимия опиатной наркомании//Нейрохимия.-2000.-Т. 17. -№1.-С. 3-12.
Закусов, В.В. Фармакология центральных синапсов/В.В. Закусов -М.: Медицина, 1973.-С. 272.
Иванец Н.Н., Анохина И.П., Стрелец Н.В. Современное состояние проблемы наркоманий в России//Журнал неврологии и психиатрии.-1997.-№ 9.-С. 4-10.
Маслов Л.Н., Лишманов Ю.Б., Смагин Г.Н. Опиоидные рецепторы. Состояние проблемы и перспективы//Экпер. и клин. фармакология.-2002.-Т. 65.-№2.-С.70-75.
Мещеряков А.Ф., Судаков С.К. Центральные механизмы формирования морфиновой зависимости//Вопросы наркологии.-1991.-№2. -С. 33-39.
Adinoff B. Neurobiologic processes in drug reward and addiction//Harv. Rev. Psychiatry.-2004.-Vol. 12.-№6. -Р. 305-320.
Bailey K.P. The brain's rewarding system & addiction//J. Psychosoc. Nurs. Ment. Health Serv.-2004.-Vol. 42.-№6. -Р. 14-18.
Bhargava H. N. Attenuation of tolerance to, and physical dependence on, morphin in the rat by inhibition of nitric oxide synthase//Gen. Pharmacol.-1995. -Vol. 26.-№5.-Р. 10491053.
Bolanos, C.A. Neurotrophic mechanisms in drug addiction//Neuromolecular. Med. -2004.-Vol. 5.-№1.-Р. 69-83.
Cami, J. Drug addiction//N. Engl. J.Med.-2003.-Vol. 349.-№10.-Р. 975-86.
Carboni E., Acquas Е., Leone Р. et al. 5HT3 receptor antagonists block morphine-and nicotine-but not amphetamine-induced reward///Psychopharmacology (Berl). -1989.-Vol. 97.-№2.-Р. 175178.
Darland, T. Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more//Trends Neurosci.-1998.-Vol. 21.-№5.-Р. 215-221.
Dole, V.P. Biochemistry of addiction//Ann. Rev. biochem.-1970.-Vol. 39.-Р. 821-840.
Domino, E.F. Opiate interactions with cholinergic neurons//Adv. Biochem. Psychopharmacol.-1979.-№20.-Р. 339-355.
Ernst M., Kimes А^., Jazbec S. Neuroimaging and mechanisms of drug abuse: interface of molecular imaging and molecular genetics//Neuroimaging Clin. N. Am. -2003.-Vol. 13.-№4.-Р. 833849.
Fox A.W. Modern opioids: uses defined by chrono-pharmacology, not receptor selectivity//J. R. Soc. Med.-1995.-Vol. 88.-№9.-Р. 502-504.
Gianoulakis C. Endogenous opioids and addiction to alcohol and other drugs of abuse//Curr. Top. Med. Chem.-2004.-Vol. 4.-№1.-Р. 39-50.
Herz A. Opioid reward mechanisms: a key role in drug abuse?//Can. J. Physiol. Pharmacol.-1998.-Vol. 76.-№3.-Р. 252-258.
Jordan B.A., Cvejic S., Devi L.A. Opioids and their complicated receptor complexes//Neuropsychopharmacology.-2000. -Vol. 23.-Suppl 4.-Р. 5-18.
Koob G.F. Neuroscience of addiction//Neuron.-1998.-№21.-P. 467-476.
Koob A.J., Roberts G., Schulteis et al. Neurocircuitry targets in ethanol reward G.F. and dependence//Alcoholism: Clin. And Exp. Res.-1998.-Vol. 21.-№ 1.-P. 3-9.
Marinelli S., Connor M., Schnell S.A. et al. Delta-opioid receptor-mediated actions on rostral ventromedial medulla neurons//Neuroscience.-2005.-Vol. 132.-№2.-Р. 239-244.
McBride W.J. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies//Behav. Brain Res.-1999.-Vol. 101.-№2.-Р. 129-152.
Nestler E.J. Molecular mechanisms of drug addiction//Neuropharmacology. -2004.-Vol. 47.-Suppl 1.-Р. 24-32.
Nutt D.J. Addiction: brain mechanisms and their treatment implications//Lancet.-1996.-Vol. 347.-№ 8993.-P. 31-36.
Oswald L.M., Wand G.S. Opioids and alcoholism.//Physiol. Behav.-2004.-Vol. 81.-№2.-Р. 339-358.
Palmada M. Excitatory amino acid neurotransmission. Pathways for metabolism, storage and reuptake of glutamate in brain//Front. Biosci.-1998.-Vol. 20.-№3.-P. 701-718.
Pasternak G.W. Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance//Neuropsychopharmacology.-1995.-Vol. 13.-№ 4.-P. 309-313.
Pulvirenti L. NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat//Brain Res.-1992.-Vol. 594.-№ 2.-P. 327-330.
Quock R.M., Burkey T.H., Varga E. et al. The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy//Pharmacol. Rev.-1999.-Vol. 51.-№3.-Р. 503-532.
Sadee W. Basal opioid receptor activity, neutral antagonists, and therapeutic opportunities//Life Sci.-2005.-Vol. 76.-№13.-Р. 1427-1437.
Sharp B.M., Roy S., Bidlack J.M. Evidence for opioid receptors on cells involved in host defense and the immune system//J. Neuroimmunol.-1998.-Vol. 83.-№ 1-2.-P. 45-56.
Shippenberg T.S. The neurobiology of opiate reinforcement//Crit. Rev. Neurobiol.-1998.-№12.-Р. 267-303.
Stefano G.B., Goumon Y., Casares F. et al. Endogenous morphine//Trends. Neurosci.-2000.-Vol. 23.-№9.-P. 436-442.
Swift R.M. Drug therapy for alcohol dependence//N. Engl. J. Med.-1999.-Vol. 340.-P. 1482-1490.
Tomkins D.M., Sellers Е.М. Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence//CMA j.-2001.-Vol. 164.-№6.-Р. 817-821.
Tsuji М., Takeda Н., Matsumiya Т. et al. A novel kappa-opioid receptor agonist, TRK-820, blocks the development of physical dependence on morphine in mice//Life Sci.-2000.-Vol. 66.-№25.-P. 353-358.
Vries T.J. Neuronal systems underlying opiate addiction//J. of Neuroscience.-2002. -Vol. 22.-№ 9.-Р. 3321-3325.
Wenger T. Neuromorphological background of cannabis addiction//Brain Res. Bull. -2003.-Vol. 61.-№2.-Р. 125-128.
